Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

Zhongmin Xiang, Marta Valenza, Libin Cui, Valerio Leoni, Hyun Kyung Jeong, Elisa Brilli, Jiangyang Zhang, Qi Peng, Wenzhen Duan, Steven A. Reeves, Elena Cattaneo, Dimitri Krainc

Research output: Contribution to journalArticle

Abstract

The peroxisome-proliferator-activated receptor gamma coactivator 1 α (PGC1α) has been implicated in the pathogenesis of several neurodegenerative disorders, including Huntington's disease (HD). Recent data demonstrating white matter abnormalities in PGC1α knock-out (KO) mice prompted us to examine the role of PGC1α in CNS myelination and its relevance to HD pathogenesis. We found deficient postnatal myelination in the striatum of PGC1α KO mice, accompanied by a decrease in myelin basic protein (MBP). In addition, brain cholesterol, its precursors, and the rate-limiting enzymes for cholesterol synthesis, HMG CoA synthase (HMGCS1) and HMG CoA reductase (HMGCR), were also reduced in PGC1α KO mice. Moreover, knockdown of PGC1α in oligodendrocytes by lentiviral shRNA led to a decrease in MBP, HMGCS1, and Hmgcr mRNAs. Chromatin immunoprecipitations revealed the recruitment of PGC1α to MBP promoter in mouse brain, and PGC1α over-expression increased MBP and SREBP-2 promoter activity, suggesting that PGC1α regulates MBP and cholesterol synthesis at the transcriptional level. Importantly, expression of mutant huntingtin (Htt) in primary oligodendrocytes resulted in decreased expression of PGC1α and its targets HmgcS1, Hmgcr, and MBP. Decreased expression of MBP and deficient myelination were found postnatally and in adult R6/2 mouse model of HD. Diffusion tensor imaging detected white matter abnormalities in the corpus callosum of R6/2 mice, and electron microscopy revealed thinner myelin sheaths and increased myelin periodicity in BACHD [bacterial artificial chromosome (BAC)-mediated transgenic model for Huntington's disease] mice expressing full-length mutant Htt. Together, these data suggest that PGC1α plays a role in postnatal myelination and that deficient PGC1α activity in oligodendrocytes may contribute to abnormal myelination in HD.

Original languageEnglish
Pages (from-to)9544-9553
Number of pages10
JournalJournal of Neuroscience
Volume31
Issue number26
DOIs
Publication statusPublished - Jun 29 2011

Fingerprint

Myelin Basic Protein
Huntington Disease
Theoretical Models
Oligodendroglia
Knockout Mice
Cholesterol
Myelin Sheath
Hydroxymethylglutaryl-CoA Synthase
Hydroxymethylglutaryl CoA Reductases
Bacterial Artificial Chromosomes
Diffusion Tensor Imaging
Corpus Callosum
Chromatin Immunoprecipitation
Brain
Periodicity
peroxisome-proliferator-activated receptor-gamma coactivator-1
Neurodegenerative Diseases
Small Interfering RNA
Electron Microscopy
Messenger RNA

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. / Xiang, Zhongmin; Valenza, Marta; Cui, Libin; Leoni, Valerio; Jeong, Hyun Kyung; Brilli, Elisa; Zhang, Jiangyang; Peng, Qi; Duan, Wenzhen; Reeves, Steven A.; Cattaneo, Elena; Krainc, Dimitri.

In: Journal of Neuroscience, Vol. 31, No. 26, 29.06.2011, p. 9544-9553.

Research output: Contribution to journalArticle

Xiang, Z, Valenza, M, Cui, L, Leoni, V, Jeong, HK, Brilli, E, Zhang, J, Peng, Q, Duan, W, Reeves, SA, Cattaneo, E & Krainc, D 2011, 'Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease', Journal of Neuroscience, vol. 31, no. 26, pp. 9544-9553. https://doi.org/10.1523/JNEUROSCI.1291-11.2011
Xiang, Zhongmin ; Valenza, Marta ; Cui, Libin ; Leoni, Valerio ; Jeong, Hyun Kyung ; Brilli, Elisa ; Zhang, Jiangyang ; Peng, Qi ; Duan, Wenzhen ; Reeves, Steven A. ; Cattaneo, Elena ; Krainc, Dimitri. / Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 26. pp. 9544-9553.
@article{e60cf22fca974c73ad66bc785a1c4a73,
title = "Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease",
abstract = "The peroxisome-proliferator-activated receptor gamma coactivator 1 α (PGC1α) has been implicated in the pathogenesis of several neurodegenerative disorders, including Huntington's disease (HD). Recent data demonstrating white matter abnormalities in PGC1α knock-out (KO) mice prompted us to examine the role of PGC1α in CNS myelination and its relevance to HD pathogenesis. We found deficient postnatal myelination in the striatum of PGC1α KO mice, accompanied by a decrease in myelin basic protein (MBP). In addition, brain cholesterol, its precursors, and the rate-limiting enzymes for cholesterol synthesis, HMG CoA synthase (HMGCS1) and HMG CoA reductase (HMGCR), were also reduced in PGC1α KO mice. Moreover, knockdown of PGC1α in oligodendrocytes by lentiviral shRNA led to a decrease in MBP, HMGCS1, and Hmgcr mRNAs. Chromatin immunoprecipitations revealed the recruitment of PGC1α to MBP promoter in mouse brain, and PGC1α over-expression increased MBP and SREBP-2 promoter activity, suggesting that PGC1α regulates MBP and cholesterol synthesis at the transcriptional level. Importantly, expression of mutant huntingtin (Htt) in primary oligodendrocytes resulted in decreased expression of PGC1α and its targets HmgcS1, Hmgcr, and MBP. Decreased expression of MBP and deficient myelination were found postnatally and in adult R6/2 mouse model of HD. Diffusion tensor imaging detected white matter abnormalities in the corpus callosum of R6/2 mice, and electron microscopy revealed thinner myelin sheaths and increased myelin periodicity in BACHD [bacterial artificial chromosome (BAC)-mediated transgenic model for Huntington's disease] mice expressing full-length mutant Htt. Together, these data suggest that PGC1α plays a role in postnatal myelination and that deficient PGC1α activity in oligodendrocytes may contribute to abnormal myelination in HD.",
author = "Zhongmin Xiang and Marta Valenza and Libin Cui and Valerio Leoni and Jeong, {Hyun Kyung} and Elisa Brilli and Jiangyang Zhang and Qi Peng and Wenzhen Duan and Reeves, {Steven A.} and Elena Cattaneo and Dimitri Krainc",
year = "2011",
month = "6",
day = "29",
doi = "10.1523/JNEUROSCI.1291-11.2011",
language = "English",
volume = "31",
pages = "9544--9553",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "26",

}

TY - JOUR

T1 - Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

AU - Xiang, Zhongmin

AU - Valenza, Marta

AU - Cui, Libin

AU - Leoni, Valerio

AU - Jeong, Hyun Kyung

AU - Brilli, Elisa

AU - Zhang, Jiangyang

AU - Peng, Qi

AU - Duan, Wenzhen

AU - Reeves, Steven A.

AU - Cattaneo, Elena

AU - Krainc, Dimitri

PY - 2011/6/29

Y1 - 2011/6/29

N2 - The peroxisome-proliferator-activated receptor gamma coactivator 1 α (PGC1α) has been implicated in the pathogenesis of several neurodegenerative disorders, including Huntington's disease (HD). Recent data demonstrating white matter abnormalities in PGC1α knock-out (KO) mice prompted us to examine the role of PGC1α in CNS myelination and its relevance to HD pathogenesis. We found deficient postnatal myelination in the striatum of PGC1α KO mice, accompanied by a decrease in myelin basic protein (MBP). In addition, brain cholesterol, its precursors, and the rate-limiting enzymes for cholesterol synthesis, HMG CoA synthase (HMGCS1) and HMG CoA reductase (HMGCR), were also reduced in PGC1α KO mice. Moreover, knockdown of PGC1α in oligodendrocytes by lentiviral shRNA led to a decrease in MBP, HMGCS1, and Hmgcr mRNAs. Chromatin immunoprecipitations revealed the recruitment of PGC1α to MBP promoter in mouse brain, and PGC1α over-expression increased MBP and SREBP-2 promoter activity, suggesting that PGC1α regulates MBP and cholesterol synthesis at the transcriptional level. Importantly, expression of mutant huntingtin (Htt) in primary oligodendrocytes resulted in decreased expression of PGC1α and its targets HmgcS1, Hmgcr, and MBP. Decreased expression of MBP and deficient myelination were found postnatally and in adult R6/2 mouse model of HD. Diffusion tensor imaging detected white matter abnormalities in the corpus callosum of R6/2 mice, and electron microscopy revealed thinner myelin sheaths and increased myelin periodicity in BACHD [bacterial artificial chromosome (BAC)-mediated transgenic model for Huntington's disease] mice expressing full-length mutant Htt. Together, these data suggest that PGC1α plays a role in postnatal myelination and that deficient PGC1α activity in oligodendrocytes may contribute to abnormal myelination in HD.

AB - The peroxisome-proliferator-activated receptor gamma coactivator 1 α (PGC1α) has been implicated in the pathogenesis of several neurodegenerative disorders, including Huntington's disease (HD). Recent data demonstrating white matter abnormalities in PGC1α knock-out (KO) mice prompted us to examine the role of PGC1α in CNS myelination and its relevance to HD pathogenesis. We found deficient postnatal myelination in the striatum of PGC1α KO mice, accompanied by a decrease in myelin basic protein (MBP). In addition, brain cholesterol, its precursors, and the rate-limiting enzymes for cholesterol synthesis, HMG CoA synthase (HMGCS1) and HMG CoA reductase (HMGCR), were also reduced in PGC1α KO mice. Moreover, knockdown of PGC1α in oligodendrocytes by lentiviral shRNA led to a decrease in MBP, HMGCS1, and Hmgcr mRNAs. Chromatin immunoprecipitations revealed the recruitment of PGC1α to MBP promoter in mouse brain, and PGC1α over-expression increased MBP and SREBP-2 promoter activity, suggesting that PGC1α regulates MBP and cholesterol synthesis at the transcriptional level. Importantly, expression of mutant huntingtin (Htt) in primary oligodendrocytes resulted in decreased expression of PGC1α and its targets HmgcS1, Hmgcr, and MBP. Decreased expression of MBP and deficient myelination were found postnatally and in adult R6/2 mouse model of HD. Diffusion tensor imaging detected white matter abnormalities in the corpus callosum of R6/2 mice, and electron microscopy revealed thinner myelin sheaths and increased myelin periodicity in BACHD [bacterial artificial chromosome (BAC)-mediated transgenic model for Huntington's disease] mice expressing full-length mutant Htt. Together, these data suggest that PGC1α plays a role in postnatal myelination and that deficient PGC1α activity in oligodendrocytes may contribute to abnormal myelination in HD.

UR - http://www.scopus.com/inward/record.url?scp=79959986144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959986144&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1291-11.2011

DO - 10.1523/JNEUROSCI.1291-11.2011

M3 - Article

C2 - 21715619

AN - SCOPUS:79959986144

VL - 31

SP - 9544

EP - 9553

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 26

ER -